Dark

Check out our API

BIOQ
BIOQUAL INC
stock OTC

Inactive

Sep 19, 2024

67.50USD-3.571%(-2.50)850

Pre-market

0.00USD-100.000%(-70.00)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 21, 2022

11:02AM EST BIOQUAL Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2022 Business Wire

Oct 22, 2021

11:07AM EDT BIOQUAL Presents Unaudited Financial Results for First Quarter of Fiscal Year 2022 Business Wire

Sep 17, 2021

10:50AM EDT BIOQUAL Presents Financial Results for Fiscal Year 2021 and Declares Dividend Business Wire

Apr 21, 2021

10:19AM EDT BIOQUAL Presents Unaudited Financial Results for Third Quarter of Fiscal Year 2021 Business Wire

Jan 22, 2021

11:41AM EST John C. Landon, Founder of BIOQUAL, Inc., Passes Away at the Age Of 84 Business Wire

09:41AM EST BIOQUAL Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2021 Business Wire

Oct 21, 2020

12:26PM EDT BIOQUAL Presents Unaudited Financial Results for First Quarter of Fiscal Year 2021 Business Wire

Sep 21, 2020

12:14PM EDT BIOQUAL Announces Publication of an Investigational COVID-19 Vaccine Candidate That Prevents Severe Clinical Disease in Animals Business Wire

Sep 15, 2020

10:52AM EDT BIOQUAL Presents Financial Results for Fiscal Year 2020 and Declares Dividend Business Wire

Aug 10, 2020

11:39AM EDT BIOQUAL Announces Publication in The New England Journal of Medicine of Non-Human Primate Preclinical Viral Challenge Study of an mRNA Vaccine Against COVID-19 (mRNA-1273) Business Wire

Jul 31, 2020

11:13AM EDT BIOQUAL Announces Publication in Nature of Non-Human Primate Preclinical Viral Challenge Study of Single-shot Ad26 vaccine protects against SARS-CoV-2 Business Wire

Share